Volver a Agenda
Session Chair(s)
Stacey Fung, PHARMD
Head, Global Medical Information
Gilead Sciences, United States
Learning Objective : Describe innovative collaboration models with FDA for communicating information; Discuss how patients participate on the review of product information and communications produced by the EMA; Identify available information expanded access programs including ways forthe pharmaceutical industry to share this information with patients and health care providers.
Speaker(s)
The FDA and Innovative Collaborations to Broaden the Reach of Health Care Messages to the Public
Anna Fine, PHARMD, MS
National Institutes of Health (NIH), United States
Interim Director for ClinicalTrials.gov
Industry Perspective
Julia Petses, PHARMD
Novartis, United States
Global Head, Medical Information Excellence and SEC Established and Rare Franchi
EMA Perspective on Communicating Health Care Messages to the Public
Martin Harvey Allchurch, LLM
European Medicines Agency, Netherlands
Head of International Affairs
¿Tiene una cuenta?